Podcast - Microbe Talk

📣 Episode 187 is out now! It's the most abundant eukaryotic microbe in humans… But what role does it play in our bodies? For decades, Blastocystis has been thought of as a parasite just like other protists that lurk within humans, such as Plasmodium or Giardia. But research is increasingly finding the opposite to be true, and scientists across the world are fighting to change this perception.

📣 Episode 186 is out now! This month, Lilly welcomes Dr Jason Brown from the University of Glasgow to discuss his latest research findings using cold atmospheric plasma (CAP), a form of ionised gas, against biofilms in wound infections. Listen in to hear their discussion of what CAP therapy is, how it works, and why this treatment could be a useful alternative to antibiotics. 

📣 Episode 185 is out now! This month, Lilly welcomes Dr Hannah Trivett from the University of Birmingham to the podcast, to discuss her latest publication bringing patient and public involvement (PPI) and microbial genomics research together for the first time ever. Listen in to hear their discussion of what the public think about effective science communication and how researchers can benefit from incorporating this into their work.

📣 Episode 183 of Microbe Talk is out now!

In this month's Microbe Talk, Charlotte Holtum (Head of Engagement & Storytelling) welcomes guests Dr Alicia Demirjian (UK Health Security Agency and Guy’s and St. Thomas’ NHS Foundation Trust) and Dr Yoann Personne (bioMérieux), to explore an underdiscussed corner of the antimicrobial resistance conversation: its management with sepsis. They discuss what underpins the real-world relationship of AMR and sepsis, improving antibiotic stewardship in hospitals, and addressing these issues sooner rather than later.

In this month's Microbe Talk, Lilly chats with microbiologist Prof Wilhelmina Huston about what science knows so far about the relationship between the vaginal microbiome - the composition of microbes that live on and within the vagina - and sexual health, including her recent research investigating how the microbial composition of the vagina can impact susceptibility to painful conditions, like pelvic inflammatory disease (PID). We also cover current treatments and where the future of treatment of STIs and other sexual health disorders is headed.

In this month's Microbe Talk, we chat to expert Kinga Kowalewska-Grochowska at the University of Alberta, Canada, following her latest review 'Parasitology of the twenty-first century: are we moving in the right direction?', published in the Journal of Medical Microbiology.

In 2019, a mysterious contaminant lead to the start of Contamination Club, an online club dedicated to weird and wonderful intruders. In this month's Microbe Talk, two of the team, Rob Moran and Greg McCallum, join us to talk about their journey and the online community that they've built.

In this episode of Microbe Talk, Clare talks to An Bui from the Department of Psychiatry at the University of Alberta about their paper published in Microbiology, the first systematic review of the potential effects of psychotropics (the drugs used to treat bipolar disorder) on the gut microbiome of treated and untreated bipolar individuals.

In January 2024, Aline Metris and Lindsay Hall hosted an academic-industry workshop at the Microbiology Society offices to discuss the potential long-term implications of microbiome perturbations.
Since then, they’ve published a comprehensive summary of the findings from the workshop in Microbial Genomics. We invited them back to the Microbiology Society offices to chat with Clare about their experiences hosting the workshop and share their insights from the paper.

For this episode of Microbe Talk Clare was joined by the wonderful Gwyn Dahlquist-Axe and Francesca Standeven, archaeological scientists who study AMR and ancient human oral microbiomes. They're on the podcast to discuss their review into diet, disease and antibiotic resistance from ancient human oral microbiomes published in Microbial Genomics.

Yesterday, we released our vision statement for Knocking Out Antimicrobial Resistance, the Society's new cross-disciplinary project. It outlined the key issues faced by the AMR community: the lack of understanding of the urgency of the crisis, a fragmented AMR landscape and a broken innovation pipeline.

So for this special Knocking Out AMR episode of Microbe Talk Clare spoke to Professor Paul Hoskisson to pick his brain on his latest venture: a one million pound project to use food by-products make antimicrobial production more cost effective and sustainable.